Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
First, we consider findings from post-marketing reports, which represent analyses of data reported to Food and Drug Administration (FDA) by prescribers and/or patients
This article is strictly for informational purposes and does not replace the advice of a healthcare professional.
A phase 2b study in patients with NASH (stage 1-3) is evaluating the efficacy of 72 weeks of emiricasan 10 or 100 mg (ENCORE-NF, NCT02686762)
However, multiple recent well-conducted studies and meta-analyses reported a risk of heart disease and stroke that is equivalent if not higher in women compared with men who have diabetes
US$ 20.76
US$ 24.53
US$ 29.84
US$ 22.37
US$ 23.75
US$ 24.54
US$ 22.42
US$ 21.52
US$ 22.37
